Abstract
C20H18ClNO3, monoclinic, P21 (no. 4), a = 11.6954(2) Å, b = 5.7274(10) Å, c = 26.5974(5) Å, β = 102.177(10)°, V = 1741.52(5) Å3, Z = 4, Rgt (F) = 0.0282, wRref (F 2) = 0.0728, T = 170(2) K.
Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Data collection and handling.
| Crystal: | Colourless block |
| Size: | 0.12 × 0.11 × 0.1 mm |
| Wavelength: | CuKα radiation (1.54178 Å) |
| μ: | 2.10 mm−1 |
| Diffractometer, scan mode: | Bruker APEX-II, φ and ω |
| θ max, completeness: | 68.2°, >99 % |
| N(hkl)measured, N(hkl)unique, R int: | 13,354, 5868, 0.037 |
| Criterion for I obs, N(hkl)gt: | I obs > 2σ(I obs), 5516 |
| N(param)refined: | 455 |
| Programs: | Bruker [1], Olex2 [2], SHELX [3] |
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).
| Atom | x | y | z | U iso*/U eq |
|---|---|---|---|---|
| Cl1 | −0.34374 (6) | 0.83578 (17) | 0.63690 (3) | 0.0624 (2) |
| N1 | −0.11828 (18) | 0.7835 (4) | 0.66820 (8) | 0.0394 (5) |
| O1 | −0.32959 (13) | 0.4564 (3) | 0.50785 (7) | 0.0420 (4) |
| C1 | −0.3851 (2) | 0.2463 (6) | 0.51799 (13) | 0.0517 (7) |
| H1A | −0.465894 | 0.244773 | 0.498222 | 0.078* |
| H1B | −0.384932 | 0.236562 | 0.554784 | 0.078* |
| H1C | −0.342660 | 0.112470 | 0.507949 | 0.078* |
| N2 | 0.71555 (17) | 0.9956 (4) | 0.78060 (9) | 0.0410 (5) |
| O2 | 0.39573 (16) | 0.3806 (3) | 0.72291 (7) | 0.0456 (4) |
| Cl2 | 0.91803 (5) | 0.83284 (15) | 0.82375 (3) | 0.05241 (19) |
| C2 | −0.21311 (18) | 0.4805 (4) | 0.53044 (9) | 0.0301 (5) |
| C3 | −0.16247 (19) | 0.6886 (4) | 0.51665 (8) | 0.0310 (5) |
| H3 | −0.209143 | 0.796354 | 0.494017 | 0.037* |
| O3 | 0.37154 (13) | 0.7588 (3) | 0.70261 (6) | 0.0340 (4) |
| C4 | −0.04707 (19) | 0.7360 (4) | 0.53558 (8) | 0.0286 (4) |
| H4 | −0.014540 | 0.878008 | 0.526573 | 0.034* |
| O4 | 0.85661 (14) | 0.1987 (4) | 0.97896 (7) | 0.0469 (5) |
| C5 | 0.02454 (18) | 0.5760 (4) | 0.56844 (8) | 0.0248 (4) |
| O5 | 0.10346 (14) | 0.3451 (3) | 0.80015 (6) | 0.0374 (4) |
| C6 | −0.02654 (17) | 0.3667 (4) | 0.58235 (7) | 0.0240 (4) |
| O6 | 0.17294 (13) | 0.7098 (3) | 0.80022 (7) | 0.0397 (4) |
| C7 | −0.14748 (17) | 0.3234 (4) | 0.56311 (8) | 0.0270 (4) |
| H7 | −0.182648 | 0.185844 | 0.572895 | 0.032* |
| C8 | 0.04639 (18) | 0.2048 (4) | 0.61431 (8) | 0.0267 (4) |
| H8 | 0.013339 | 0.066208 | 0.624789 | 0.032* |
| C9 | 0.16415 (18) | 0.2450 (4) | 0.63036 (8) | 0.0277 (4) |
| H9 | 0.211780 | 0.132694 | 0.651271 | 0.033* |
| C10 | 0.21539 (18) | 0.4518 (4) | 0.61613 (8) | 0.0272 (4) |
| C11 | 0.14636 (18) | 0.6138 (4) | 0.58629 (8) | 0.0262 (4) |
| H11 | 0.180543 | 0.754160 | 0.577344 | 0.031* |
| C12 | 0.34708 (18) | 0.4919 (5) | 0.63329 (9) | 0.0329 (5) |
| H12 | 0.368390 | 0.635619 | 0.615998 | 0.039* |
| C13 | 0.37546 (17) | 0.5314 (4) | 0.69088 (10) | 0.0318 (5) |
| C14 | 0.4187 (2) | 0.2867 (6) | 0.61947 (11) | 0.0472 (7) |
| H14A | 0.395804 | 0.255605 | 0.582482 | 0.071* |
| H14B | 0.403894 | 0.147711 | 0.638625 | 0.071* |
| H14C | 0.502086 | 0.325650 | 0.628476 | 0.071* |
| C15 | 0.40019 (17) | 0.8140 (5) | 0.75732 (9) | 0.0355 (5) |
| H15A | 0.361931 | 0.699974 | 0.776392 | 0.043* |
| H15B | 0.370228 | 0.971437 | 0.762948 | 0.043* |
| C16 | 0.53065 (17) | 0.8071 (4) | 0.77737 (8) | 0.0296 (5) |
| C17 | 0.5870 (2) | 0.6273 (5) | 0.80751 (10) | 0.0375 (5) |
| H17 | 0.543120 | 0.501827 | 0.817271 | 0.045* |
| C18 | 0.7074 (2) | 0.6312 (5) | 0.82334 (10) | 0.0420 (6) |
| H18 | 0.748377 | 0.510043 | 0.844019 | 0.050* |
| C19 | 0.76555 (18) | 0.8184 (5) | 0.80783 (9) | 0.0342 (5) |
| C20 | 0.5986 (2) | 0.9865 (5) | 0.76568 (10) | 0.0377 (5) |
| H20 | 0.560261 | 1.112441 | 0.745719 | 0.045* |
| C21 | 0.8930 (2) | 0.0040 (6) | 0.95309 (12) | 0.0499 (7) |
| H21A | 0.881827 | 0.038808 | 0.916297 | 0.075* |
| H21B | 0.846451 | −0.133141 | 0.957938 | 0.075* |
| H21C | 0.975930 | −0.027710 | 0.967204 | 0.075* |
| C22 | 0.74210 (19) | 0.2670 (5) | 0.96335 (9) | 0.0354 (5) |
| C23 | 0.7144 (2) | 0.4753 (5) | 0.98626 (10) | 0.0397 (6) |
| H23 | 0.773387 | 0.553905 | 1.010379 | 0.048* |
| C24 | 0.6043 (2) | 0.5657 (5) | 0.97431 (9) | 0.0368 (5) |
| H24 | 0.587671 | 0.708192 | 0.989602 | 0.044* |
| C25 | 0.51390 (19) | 0.4487 (4) | 0.93910 (8) | 0.0294 (5) |
| C26 | 0.54148 (18) | 0.2353 (4) | 0.91741 (8) | 0.0275 (4) |
| C27 | 0.65768 (19) | 0.1482 (5) | 0.92931 (9) | 0.0323 (5) |
| H27 | 0.676879 | 0.008334 | 0.913762 | 0.039* |
| C28 | 0.39804 (19) | 0.5350 (4) | 0.92646 (9) | 0.0302 (5) |
| H28 | 0.380336 | 0.679784 | 0.940518 | 0.036* |
| C29 | 0.31056 (19) | 0.4142 (4) | 0.89431 (8) | 0.0300 (5) |
| C30 | 0.33770 (19) | 0.1978 (4) | 0.87369 (9) | 0.0325 (5) |
| H30 | 0.277637 | 0.110988 | 0.852012 | 0.039* |
| C31 | 0.44962 (19) | 0.1129 (4) | 0.88473 (9) | 0.0320 (5) |
| H31 | 0.466068 | −0.031478 | 0.870152 | 0.038* |
| C32 | 0.18605 (19) | 0.5100 (5) | 0.88097 (9) | 0.0333 (5) |
| H32 | 0.186871 | 0.669029 | 0.896559 | 0.040* |
| C33 | 0.1001 (2) | 0.3597 (6) | 0.90273 (9) | 0.0434 (6) |
| H33A | 0.020410 | 0.418451 | 0.890259 | 0.065* |
| H33B | 0.119712 | 0.366603 | 0.940382 | 0.065* |
| H33C | 0.104864 | 0.197731 | 0.891495 | 0.065* |
| C34 | 0.15229 (17) | 0.5372 (5) | 0.82292 (9) | 0.0318 (5) |
| C35 | 0.0841 (2) | 0.3373 (6) | 0.74429 (9) | 0.0418 (6) |
| H35A | 0.079749 | 0.172320 | 0.732917 | 0.050* |
| H35B | 0.151457 | 0.410526 | 0.733234 | 0.050* |
| C36 | −0.0260 (2) | 0.4607 (4) | 0.71890 (9) | 0.0336 (5) |
| C37 | −0.1350 (2) | 0.3667 (5) | 0.71940 (9) | 0.0422 (6) |
| H37 | −0.140943 | 0.223390 | 0.736646 | 0.051* |
| C38 | −0.2345 (2) | 0.4818 (6) | 0.69480 (11) | 0.0462 (6) |
| H38 | −0.310173 | 0.422251 | 0.695055 | 0.055* |
| C39 | −0.2198 (2) | 0.6875 (5) | 0.66972 (9) | 0.0387 (6) |
| C40 | −0.0232 (2) | 0.6686 (5) | 0.69292 (9) | 0.0358 (5) |
| H40 | 0.051183 | 0.734564 | 0.692552 | 0.043* |
1 Source of materials
Naproxen acylchloride was synthesized according to the literature [4]. 2–Chloro-5-hydroxymethylpyridine (0.01 mol, 1.43 g) and 4-(dimethylamino)-pyridin (DMAP, 0.0015 mol, 0.18 g) were dissolved in dry tetrahydrofuran (20 mL) and triethylamine (0.015 mol, 2 mL). The solution of naproxen acylchloride in dry tetrahydrofuran was dropwise added at 0 °C. The reaction mixture was stirred for 2 h at room temperature. The mixture was filtrated to remove the solid and the filtrate was concentrated under vacuum to remove the solvent. The residue was dissolved in dichloromethane, successively washed with 5 % NaOH solution and water to pH = 7, and dried with anhydrous Na2SO4. The solution was filtrated, and concentrated under vacuum to obtain crude product. The crude product was purified by recrystallization in ethanol. The crystals were obtained from tetrahydrofuran.
2 Experimental details
The U iso values were set to be 1.5U eq of the carrier atom for methyl H atoms and 1.2U eq for the remaining H atoms.
3 Comment
Naproxen is often used for treating rheumatic, rheumatoid arthritis and osteoarthritis as a nonsteroidal anti-inflammatory drug. There is a carboxylic acid group in the structure which can bring ulcers, gastric perforation and bleeding gastrointestinal side effects for long-term using [5, 6]. Studies have shown that esterification of naproxen as a prodrug can reduce gastrointestinal side effects of naproxen and improve its bioavailability [7]. This study esterifies the carboxyl group in the naproxen molecule with the 2-chloro-5-hydroxymethylpyridine hydroxyl group to form a prodrug, with the aim of changing the physicochemical properties of naproxen and providing a prodrug with a tendency to reduce gastric irritation.
The compound contains two twist (6-chloropyridin-3-yl)methyl 2-(6-methoxynaphthalen-2-yl)propanoate molecules in the asymmetric unit (see the figure). The title compound contained one pyridine ring and one naphthyl moiety. The C=O double bond lengths in the independent molecule are 1.201(3) Å (C13=O2) and 1.209(3) Å (C34=O6), respectively, exhibiting the double bond character. The dihedral angles of ring 1 (C2–C3–C4–C5–C6–C7) and ring 2 (C5–C6–C8–C9–C10–C11), ring 1 (C2–C3–C4–C5–C6–C7) and ring 3 (C16–C17–C18–C19–N2–C20), ring 2 (C5–C6–C8–C9–C10–C11) and ring 3 (C16– C17–C18–C19–N2–C20), ring 4 (C22–C23–C24–C25–C26–C27) and ring 5 (C26–C25–C28–C29–C30–C31), ring 4 (C22–C23–C24–C25–C26–C27) and ring 6 (C36–C37–C38–C39–N1–C40), ring 5 (C26–C25–C28–C29–C30–C31) and ring 6 (C36–C37–C38–C39–N1–C40) are 3.1°, 8.0°, 5.3°, 2.6°, 62.9°, 60.7°, respectively. The other bond distances and angles are in their normal ranges according to the previously reported compounds [8–10].
-
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
-
Competing interests: The authors declare no conflicts of interest regarding this article.
References
1. Bruker. SAINT and SADABS; Bruker AXS Inc.: Madison, Wisconsin, USA, 2000.Suche in Google Scholar
2. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Suche in Google Scholar
3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar
4. Huang, Z. J., Velázquez, C. A., Abdellatif, K. R. A., Chowdhury, M. A., Reisz, J. A., DuMond, J. F., King, S. B., Knaus, E. E. Ethanesulfohydroxamic acid ester prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs): synthesis, nitric oxide and nitroxyl release, cyclooxygenase inhibition, anti-inflammatory, and ulcerogenicity index studies. J. Med. Chem. 2011, 54, 1356–1364; https://doi.org/10.1021/jm101403g.Suche in Google Scholar PubMed
5. Rainsford, K. D. Profile and mechanisms of gastrointestinal and other side effects of nonsteroidal anti-inflammatory drugs (NSAIDs). Am. J. Med. 1999, 107, 27–35; https://doi.org/10.1016/s0002-9343(99)00365-4.Suche in Google Scholar PubMed
6. Angel, L., Jose, M. A. Cost stratification of nonsteroidal antiinflammatory drug-associated gastrointestinal side effects. Gastroenterology 2000, 118, A251; https://doi.org/10.1016/s0016-5085(00)83080-2.Suche in Google Scholar
7. Rautio, J., Nevalainen, T., Taipale, H., Vepsalainen, J., Gynther, J., Laine, K., Jarvinen, T. Piperazinylalkyl prodrugs of naproxen improve in vitro skin permeation. Eur. J. Pharm. Sci. 2000, 11, 157–163; https://doi.org/10.1016/s0928-0987(00)00090-7.Suche in Google Scholar PubMed
8. Wang, L. L., Xue, D. D. Crystal structure of 3-phenylpropyl 2-(6-methoxynaphthalen-2-yl)propagate, C23H24O3. Z. Kristallogr. N. Cryst. Struct. 2022, 237, 517–519; https://doi.org/10.1515/ncrs-2022-0114.Suche in Google Scholar
9. Liang, D., Yang, X. H., Sun, W., Wang, W. N., Yang, J. Z., Liu, Y. Y., Wang, G. S. Synthesis, crystal structure and biological activities of naproxen-eugenol ester prodrug. Chem. Res. Chin. Univ. 2013, 29, 245–248; https://doi.org/10.1007/s40242-013-2266-9.Suche in Google Scholar
10. Vasylyeva, V., Hofmann, D. W. M., Mera, K. Crystal structures of 2-chloropyridine and 2-fluoropyridine: isostructural crystal packing or not? Struct. Chem. 2016, 27, 331–339; https://doi.org/10.1007/s11224-015-0603-y.Suche in Google Scholar
© 2024 the author(s), published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 International License.
Artikel in diesem Heft
- Frontmatter
- New Crystal Structures
- The crystal structure of tris((Z)-2-hydroxy-N-((E)-pyridin-2-ylmethylene)benzohydrazonato-k2O,N)europium(III), C39H30N9O6Eu
- Crystal structure of (E)-3-(benzylideneamino)-2-phenylthiazolidin-4-one, C16H14N2OS
- The crystal structure of (E)-4-fluoro-N′-(1-(o-tolyl)ethylidene)benzohydrazide, C16H15FN2O
- Crystal structure of (6-chloropyridin-3-yl)methyl 2-(6-methoxynaphthalen-2-yl)propanoate, C20H18ClNO3
- Crystal structure of methyl 3-methoxy-4-(2-methoxy-2-oxoethoxy)benzoate, C12H14O6
- The crystal structure of bis[(4-methoxyphenyl)(picolinoyl)amido-κ2 N:N′]copper(II), C26H22CuN4O4
- The crystal structure of poly[di(μ2-aqua)-diaqua-bis(3-aminopyridine-4-carboxylate-κ2 O: O′)-tetra(μ2-3-aminopyridine-4-carboxylate-κ2 O: O′)-dineodymium(III), [Nd2(C6H5N2O2)6(H2O)4] n
- The crystal structure of t-butyl 7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate, C28H34FNO4
- Crystal structure of catena-poly[(benzylamine-κ1 N)-(sorbato-κ1 O)-(μ2-sorbato-κ2 O,O′)-copper(II), C19H23CuNO4
- Crystal structure of (4-(2-chlorophenyl)-1H-pyrrol-3-yl)(ferrocenyl) methanone, C21H16ClFeNO
- The crystal structure of N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-3-(2-methylphenyl)-2-sulfanylprop-2-enamide hydrate, C19H17BrN2O2S2
- The crystal structure of N′-{5-[2-(2,6-dimethylphenoxy) acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl}-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide hydrate
- Crystal structure of 2-(naphthalen-1-yl)ethyl 2-(6-methoxynaphthalen-2-yl)propanoate, C26H24O3
- Crystal structure of naphthalen-1-ylmethyl 2-(6-methoxynaphthalen-2-yl)propanoate, C25H22O3
- Crystal structure of poly[diaqua- (μ4-5-(1H-1,2,4-triazol-1-yl)benzene-1,3-dicarboxylato-κ5N:O,O’:O’’:O’’’)calcium(II), C10H9CaN3O6
- Crystal structure of (E)-N′-(4-((E)-3-(dimethylamino)acryloyl)-3-hydroxyphenyl)-N, N-dimethylformimidamide, C14H19N3O2
- Crystal structure of (E)-3-(dimethylamino)-1-(2-hydroxy-4,6-dimethoxyphenyl)prop-2-en-1-one, C13H17NO4
- Crystal structure of (2-chloropyridin-3-yl)methyl-2-(6-methoxynaphthalen-2-yl)propanoate, C20H18ClNO3
- The crystal structure of diethyl 4-(3,4-dimethylphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, C21H27NO4
- Crystal structure of (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-17-((4-(2-phenylpropyl)phenyl)ethynyl)-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one, C36H42O2
- Synthesis and crystal structure of 4-(4-cyclopropylnaphthalen-1-yl)-2,4-dihydro-3H-1,2,4-triazole-3-thione, C15H13N3S
- Crystal structure of catena-poly[aqua-(2,6-di-(2-pyridyl)-pyridine-κ3 N,N′, N″)(μ2-1,4-naphthalene dicarboxylato-κ2 O,O′)nickel(II)], C27H19NiN3O5
- Crystal structure of 3-(diphenylphosphoryl)-3-hydroxy-1-phenylpropan-1-one, C21H19O3P
- The crystal structure of R,S-{N-[(2-oxidonaphthalen-1-yl)methylidene]phenylglycinato}divinylsilicon, C23H19NO3Si
- The crystal structure of 1,2,4-tris(bromomethyl)benzene, C9H9Br3
- Crystal structure of chlorido-[4-(pyridin-2-yl)benzaldehyde-κ2 N,C]-(diethylamine-κ1 N)platinum(II), C16H18ClN2OPt
- Crystal structure of 3-(methoxycarbonyl)-1-(4-methoxyphenyl)-2,3,4,9- tetrahydro-1H-pyrido[3,4-b]indol-2-ium chloride hydrate, C40H48Cl2N4O9
- The crystal structure of 1-(2-chlorobenzyl)-3-(3-chlorophenyl)urea, C14H12Cl2N2O
- Hydrothermal synthesis and crystal structure of aqua-tris(4-acetamidobenzoato-κ2 O,O′)-(1,10-phenanthroline-κ2 N,N′)terbium(III) hydrate C39H36N5O11Tb
- The crystal structure of zwitterionic 3-aminoisonicotinic acid, C6H6N2O2
- The crystal structure of bis{[monoaqua-μ2-4-[(pyridine-4-carbonyl)-amino]-phthalato-κ3 N:O,O′-(2,2′-bipyridine κ2 N,N′)copper(II)]}decahydrate, C48H56N8O22Cu2
- Crystal structure of poly[μ10-4,4′-methylene-bis(oxy)benzoatodipotassium], C15H10K2O6
- The crystal structure of catena-poly[[tetraaqua[(μ2-1,4-di(4-methyl-1-imidazolyl)benzene] cobalt(II)]bis(formate)], C16H24CoN4O8
- The crystal structure of (E)-2-chloro-5-((2-(nitromethylene)imidazolidin-1-yl)methyl)pyridine, C10H11ClN4O2
- The crystal structure of (E)-1-(((2-amino-4,5-dimethylphenyl)iminio)methyl)naphthalen-2-olate, C19H18N2O
- Crystal structure of N-(acridin-9-yl)-2-(4-methylpiperidin-1-yl) acetamide monohydrate, C21H25N3O2
- The crystal structure of dichlorido-bis(3-methyl-3-imidazolium-1-ylpropionato-κ2 O,O′)-zinc(II), C14H20Cl2N4O4Zn
- The crystal structure of 2,8-diethyl-1,3,7,9-tetramethyl-4λ4,5λ4-spiro[dipyrrolo[1,2-c:2′,1′-f][1,3,2]diazaborinine-5,2′-naphtho[1,8-de][1,3,2]dioxaborinine], C25H29BN2O2
- The crystal structure of 5-tert-butyl-2-(5-tert-butyl-3-iodo-benzofuran-2-yl)-3-iodobenzofuran, C24H24I2O2
- Synthesis and crystal structure of methyl 2-{[4-(4-cyclopropyl-1-naphthyl)-4H-1,2,4-triazole-3-yl]thio} acetate, C18H17N3O2S
- The crystal structure of n-propylammonium bis(2,3-dimethylbutane-2,3-diolato)borate-boric acid (1/1), [C3H10N][C12H24BO4]·B(OH)3
- Crystal structure of methyl 1-(2-bromophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate, C19H17BrN2O2
- Crystal structure of (4-bromobenzyl)triphenylphosphonium bromide ethanol solvate, C52H48Br4OP2
- The crystal structure of unsymmetrical BOPHY C26H27BN4
- The crystal structure of Tb3B5O11(OH)2
- The crystal structure of (Z)-4-ethyl-2-((4-ethyl-3,5-dimethyl-1H-pyrrol-2-yl)methylene)-3,5-dimethyl-2H-pyrrol-1-ium 2,2'-spirobi[naphtho[1,8-de][1,3,2]dioxaborinin]-2-uide, C37H37BN2O4
- Crystal structure of bis(methylammonium) hexadecaselenidopalladate(II), (CH3NH3)2PdSe16
- The crystal structure of (2-diphenylphosphanylphenyl) 2-[7-(dimethylamino)-2-oxochromen-4-yl]acetate, C31H26NO4P
- Crystal structure of (E)-6-(4-ethylpiperazin-1-yl)-2-(3-fluorobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C23H25FN2O
- The structure of RUB-56, (C6H16N)8 [Si32O64(OH)8]·32 H2O, a hydrous layer silicate (2D-zeolite) that contains microporous levyne-type silicate layers
- Crystal structure of 4-amino-3,5-dibromobenzonitrile, C7H4Br2N2
- Crystal structure of 2-(naphthalen-1-yl)ethyl 2-acetoxybenzoate, C21H18O4
- Single-crystal structure determination of Tm3B12O19(OH)7
- Crystal structure determination of NdB3.6O7
- The crystal structure of NdB6O8(OH)5·H3BO3
- Crystal structure of 2-(5-ethylpyridin-2-yl)ethyl 2-(6-methoxynaphthalen-2-yl)propanoate, C23H25NO3
- Crystal structure of N-(1-(3,4-dimethoxyphenyl)-2-methylpropyl)aniline, C18H23NO2
- Crystal structure of Ba6Cd12Mn4SiF48
- Synthesis and crystal structure of 5-fluoro-1-methyl-2-oxo-3-(2-oxochroman-4-yl)indolin-3-yl acetate, C20H16FNO5
- The crystal structure of 6-methacryloylbenzo[d][1,3]dioxol-5-yl 4-nitrobenzenesulfonate, C17H13NO8S
- Crystal structure of ethyl 2-(3-benzyl-4-oxo-3,4-dihydrophthalazin-1-yl)- 2,2-difluoroacetate, C19H16F2N2O3
- The crystal structure of tetrakis(μ 2-(1H-benzimidazole-2-methoxo-κ2 N,O:O:O)-(n-butanol-κO)-chlorido)-tetranickel(II), C48H68Cl4N8O8Ni4
- Synthesis and crystal structure of trans-tetraaqua-bis((1-((7-hydroxy-3-(4-methoxy-3-sulfonatophenyl)-4-oxo-4H-chromen-8-yl)methyl)piperidin-1-ium-4-carbonyl)oxy-κO)zinc(II)hexahydrate, C46H64N2O28S2Zn
- The crystal structure of 1-(4-carboxybutyl)-3-methyl-1H-imidazol-3-ium hexafluoridophosphate, C9H15F6N2O2P
- Crystal structure of 1-(4-chlorophenyl)-4-(2-furoyl)-3-phenyl-1H-pyrazol-5-ol, C20H13ClN2O3
- Crystal structure of dimethyl (R)-2-(3-(1-phenylethyl)thioureido)-[1,1′-biphenyl]-4,4′-dicarboxylate, C25H24N2O4S
- The crystal structure of 1-(3-carboxypropyl)-1H-imidazole-3-oxide, C7H10N2O3
- Synthesis and crystal structure of dimethyl 4,4′-(propane-1,3-diylbis(oxy))dibenzoate, C19H20O6
- Crystal structure of methyl-1-(p-tolyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate, C20H20N2O2
- The crystal structure of 1-(1-adamantan-1-yl)ethyl-3-(3-methoxyphenyl)thiourea, C20H28N2OS
- The crystal structure of N,N′-carbonylbis(2,6-difluorobenzamide), C15H8F4N2O3
Artikel in diesem Heft
- Frontmatter
- New Crystal Structures
- The crystal structure of tris((Z)-2-hydroxy-N-((E)-pyridin-2-ylmethylene)benzohydrazonato-k2O,N)europium(III), C39H30N9O6Eu
- Crystal structure of (E)-3-(benzylideneamino)-2-phenylthiazolidin-4-one, C16H14N2OS
- The crystal structure of (E)-4-fluoro-N′-(1-(o-tolyl)ethylidene)benzohydrazide, C16H15FN2O
- Crystal structure of (6-chloropyridin-3-yl)methyl 2-(6-methoxynaphthalen-2-yl)propanoate, C20H18ClNO3
- Crystal structure of methyl 3-methoxy-4-(2-methoxy-2-oxoethoxy)benzoate, C12H14O6
- The crystal structure of bis[(4-methoxyphenyl)(picolinoyl)amido-κ2 N:N′]copper(II), C26H22CuN4O4
- The crystal structure of poly[di(μ2-aqua)-diaqua-bis(3-aminopyridine-4-carboxylate-κ2 O: O′)-tetra(μ2-3-aminopyridine-4-carboxylate-κ2 O: O′)-dineodymium(III), [Nd2(C6H5N2O2)6(H2O)4] n
- The crystal structure of t-butyl 7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate, C28H34FNO4
- Crystal structure of catena-poly[(benzylamine-κ1 N)-(sorbato-κ1 O)-(μ2-sorbato-κ2 O,O′)-copper(II), C19H23CuNO4
- Crystal structure of (4-(2-chlorophenyl)-1H-pyrrol-3-yl)(ferrocenyl) methanone, C21H16ClFeNO
- The crystal structure of N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-3-(2-methylphenyl)-2-sulfanylprop-2-enamide hydrate, C19H17BrN2O2S2
- The crystal structure of N′-{5-[2-(2,6-dimethylphenoxy) acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl}-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide hydrate
- Crystal structure of 2-(naphthalen-1-yl)ethyl 2-(6-methoxynaphthalen-2-yl)propanoate, C26H24O3
- Crystal structure of naphthalen-1-ylmethyl 2-(6-methoxynaphthalen-2-yl)propanoate, C25H22O3
- Crystal structure of poly[diaqua- (μ4-5-(1H-1,2,4-triazol-1-yl)benzene-1,3-dicarboxylato-κ5N:O,O’:O’’:O’’’)calcium(II), C10H9CaN3O6
- Crystal structure of (E)-N′-(4-((E)-3-(dimethylamino)acryloyl)-3-hydroxyphenyl)-N, N-dimethylformimidamide, C14H19N3O2
- Crystal structure of (E)-3-(dimethylamino)-1-(2-hydroxy-4,6-dimethoxyphenyl)prop-2-en-1-one, C13H17NO4
- Crystal structure of (2-chloropyridin-3-yl)methyl-2-(6-methoxynaphthalen-2-yl)propanoate, C20H18ClNO3
- The crystal structure of diethyl 4-(3,4-dimethylphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, C21H27NO4
- Crystal structure of (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-17-((4-(2-phenylpropyl)phenyl)ethynyl)-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one, C36H42O2
- Synthesis and crystal structure of 4-(4-cyclopropylnaphthalen-1-yl)-2,4-dihydro-3H-1,2,4-triazole-3-thione, C15H13N3S
- Crystal structure of catena-poly[aqua-(2,6-di-(2-pyridyl)-pyridine-κ3 N,N′, N″)(μ2-1,4-naphthalene dicarboxylato-κ2 O,O′)nickel(II)], C27H19NiN3O5
- Crystal structure of 3-(diphenylphosphoryl)-3-hydroxy-1-phenylpropan-1-one, C21H19O3P
- The crystal structure of R,S-{N-[(2-oxidonaphthalen-1-yl)methylidene]phenylglycinato}divinylsilicon, C23H19NO3Si
- The crystal structure of 1,2,4-tris(bromomethyl)benzene, C9H9Br3
- Crystal structure of chlorido-[4-(pyridin-2-yl)benzaldehyde-κ2 N,C]-(diethylamine-κ1 N)platinum(II), C16H18ClN2OPt
- Crystal structure of 3-(methoxycarbonyl)-1-(4-methoxyphenyl)-2,3,4,9- tetrahydro-1H-pyrido[3,4-b]indol-2-ium chloride hydrate, C40H48Cl2N4O9
- The crystal structure of 1-(2-chlorobenzyl)-3-(3-chlorophenyl)urea, C14H12Cl2N2O
- Hydrothermal synthesis and crystal structure of aqua-tris(4-acetamidobenzoato-κ2 O,O′)-(1,10-phenanthroline-κ2 N,N′)terbium(III) hydrate C39H36N5O11Tb
- The crystal structure of zwitterionic 3-aminoisonicotinic acid, C6H6N2O2
- The crystal structure of bis{[monoaqua-μ2-4-[(pyridine-4-carbonyl)-amino]-phthalato-κ3 N:O,O′-(2,2′-bipyridine κ2 N,N′)copper(II)]}decahydrate, C48H56N8O22Cu2
- Crystal structure of poly[μ10-4,4′-methylene-bis(oxy)benzoatodipotassium], C15H10K2O6
- The crystal structure of catena-poly[[tetraaqua[(μ2-1,4-di(4-methyl-1-imidazolyl)benzene] cobalt(II)]bis(formate)], C16H24CoN4O8
- The crystal structure of (E)-2-chloro-5-((2-(nitromethylene)imidazolidin-1-yl)methyl)pyridine, C10H11ClN4O2
- The crystal structure of (E)-1-(((2-amino-4,5-dimethylphenyl)iminio)methyl)naphthalen-2-olate, C19H18N2O
- Crystal structure of N-(acridin-9-yl)-2-(4-methylpiperidin-1-yl) acetamide monohydrate, C21H25N3O2
- The crystal structure of dichlorido-bis(3-methyl-3-imidazolium-1-ylpropionato-κ2 O,O′)-zinc(II), C14H20Cl2N4O4Zn
- The crystal structure of 2,8-diethyl-1,3,7,9-tetramethyl-4λ4,5λ4-spiro[dipyrrolo[1,2-c:2′,1′-f][1,3,2]diazaborinine-5,2′-naphtho[1,8-de][1,3,2]dioxaborinine], C25H29BN2O2
- The crystal structure of 5-tert-butyl-2-(5-tert-butyl-3-iodo-benzofuran-2-yl)-3-iodobenzofuran, C24H24I2O2
- Synthesis and crystal structure of methyl 2-{[4-(4-cyclopropyl-1-naphthyl)-4H-1,2,4-triazole-3-yl]thio} acetate, C18H17N3O2S
- The crystal structure of n-propylammonium bis(2,3-dimethylbutane-2,3-diolato)borate-boric acid (1/1), [C3H10N][C12H24BO4]·B(OH)3
- Crystal structure of methyl 1-(2-bromophenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate, C19H17BrN2O2
- Crystal structure of (4-bromobenzyl)triphenylphosphonium bromide ethanol solvate, C52H48Br4OP2
- The crystal structure of unsymmetrical BOPHY C26H27BN4
- The crystal structure of Tb3B5O11(OH)2
- The crystal structure of (Z)-4-ethyl-2-((4-ethyl-3,5-dimethyl-1H-pyrrol-2-yl)methylene)-3,5-dimethyl-2H-pyrrol-1-ium 2,2'-spirobi[naphtho[1,8-de][1,3,2]dioxaborinin]-2-uide, C37H37BN2O4
- Crystal structure of bis(methylammonium) hexadecaselenidopalladate(II), (CH3NH3)2PdSe16
- The crystal structure of (2-diphenylphosphanylphenyl) 2-[7-(dimethylamino)-2-oxochromen-4-yl]acetate, C31H26NO4P
- Crystal structure of (E)-6-(4-ethylpiperazin-1-yl)-2-(3-fluorobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C23H25FN2O
- The structure of RUB-56, (C6H16N)8 [Si32O64(OH)8]·32 H2O, a hydrous layer silicate (2D-zeolite) that contains microporous levyne-type silicate layers
- Crystal structure of 4-amino-3,5-dibromobenzonitrile, C7H4Br2N2
- Crystal structure of 2-(naphthalen-1-yl)ethyl 2-acetoxybenzoate, C21H18O4
- Single-crystal structure determination of Tm3B12O19(OH)7
- Crystal structure determination of NdB3.6O7
- The crystal structure of NdB6O8(OH)5·H3BO3
- Crystal structure of 2-(5-ethylpyridin-2-yl)ethyl 2-(6-methoxynaphthalen-2-yl)propanoate, C23H25NO3
- Crystal structure of N-(1-(3,4-dimethoxyphenyl)-2-methylpropyl)aniline, C18H23NO2
- Crystal structure of Ba6Cd12Mn4SiF48
- Synthesis and crystal structure of 5-fluoro-1-methyl-2-oxo-3-(2-oxochroman-4-yl)indolin-3-yl acetate, C20H16FNO5
- The crystal structure of 6-methacryloylbenzo[d][1,3]dioxol-5-yl 4-nitrobenzenesulfonate, C17H13NO8S
- Crystal structure of ethyl 2-(3-benzyl-4-oxo-3,4-dihydrophthalazin-1-yl)- 2,2-difluoroacetate, C19H16F2N2O3
- The crystal structure of tetrakis(μ 2-(1H-benzimidazole-2-methoxo-κ2 N,O:O:O)-(n-butanol-κO)-chlorido)-tetranickel(II), C48H68Cl4N8O8Ni4
- Synthesis and crystal structure of trans-tetraaqua-bis((1-((7-hydroxy-3-(4-methoxy-3-sulfonatophenyl)-4-oxo-4H-chromen-8-yl)methyl)piperidin-1-ium-4-carbonyl)oxy-κO)zinc(II)hexahydrate, C46H64N2O28S2Zn
- The crystal structure of 1-(4-carboxybutyl)-3-methyl-1H-imidazol-3-ium hexafluoridophosphate, C9H15F6N2O2P
- Crystal structure of 1-(4-chlorophenyl)-4-(2-furoyl)-3-phenyl-1H-pyrazol-5-ol, C20H13ClN2O3
- Crystal structure of dimethyl (R)-2-(3-(1-phenylethyl)thioureido)-[1,1′-biphenyl]-4,4′-dicarboxylate, C25H24N2O4S
- The crystal structure of 1-(3-carboxypropyl)-1H-imidazole-3-oxide, C7H10N2O3
- Synthesis and crystal structure of dimethyl 4,4′-(propane-1,3-diylbis(oxy))dibenzoate, C19H20O6
- Crystal structure of methyl-1-(p-tolyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate, C20H20N2O2
- The crystal structure of 1-(1-adamantan-1-yl)ethyl-3-(3-methoxyphenyl)thiourea, C20H28N2OS
- The crystal structure of N,N′-carbonylbis(2,6-difluorobenzamide), C15H8F4N2O3